Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 4Lymphoid 4Other hematologic neoplasm 3Sarcoma 2Gynecologic 2Genitourinary 2Plasma cell 1Dermatologic 1Classical hematology 1CNS 1Breast 1

Conditions

Testicular Neoplasms 30Testicular Germ Cell Tumor 17Prostatic Neoplasms 13Wilms Tumor 12Teratoma 12Ovarian Neoplasms 11Kidney Neoplasms 9Seminoma 8Endodermal Sinus Tumor 8Sarcoma 7Neuroectodermal Tumors, Primitive, Peripheral 7Central Nervous System Neoplasms 7Carcinoma, Embryonal 7Ovarian Germ Cell Cancer 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 4Osteosarcoma 4Neuroblastoma 4Neoplasms 4Melanoma 4Medulloblastoma 4Small Cell Lung Carcinoma 3Rhabdoid Tumor 3Retinoblastoma 3Optic Nerve Glioma 3Neoplasms, Germ Cell and Embryonal 3Lung Neoplasms 3Hepatoblastoma 3Breast Neoplasms 3Astrocytoma 3

Interventions

Cisplatin 3Etoposide 2Bleomycin 2Amifostine 2pazopanib 1glucarpidase 1Social Determinants of Health 1Methotrexate 1Gemcitabine 1Chemotherapy, Adjuvant 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Etoposide × Genitourinary × Clear all
NCT00324298 2013-08-12

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

National Cancer Institute (NCI)

Phase 3 Completed
210 enrolled
Genitourinary

Testicular Germ Cell Tumor, Testicular Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00003811 2013-07-04

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
27 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡